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Background: Unfractionated heparin (UFH) is standard ancillary therapy alongside primary percutaneous coronary intervention (PCI) for 
ST-elevation myocardial infarction (STEMI). Little is known about the influence of renal insufficiency (glomerular filtration rate (GFR) <60 ml/
min/1.73m2) on anticoagulation levels, bleeding and mortality during treatment with UFH. 
Methods: In 1513 patients APTT and GFR data were available. GFR was calculated using the Cockcroft-Gault formula. Patients were stratified into 
2 groups: GFR < 60 ml/min, GFR > 60 ml/min. Major bleeding was defined as a decrease in the serum hemoglobin level of 4 g/dL or 3 g/dL with 
an overt bleeding source, a hematoma that was 5 cm or larger or that required diagnostic or surgical intervention, or an overt bleeding source that 
required blood transfusion. Odds ratios for major bleeding were calculated using logistic regression analysis and adjusted for age sex, and GP IIb/
IIIa inhibitor use. Hazard ratios for 30-day and 1-year mortality were calculated using Cox regression analysis and adjusted for age, sex, smoking 
habits, LAD/ LM related infarction and the presence of shock. 
Results: Results are shown in Table 1. 
Conclusions: Renal insufficiency led to marked over-anticoagulation resulting in more major bleedings, 30-day and 1-year mortality. This 
underlines the importance of adjusting UFH dose for patients with renal insufficiency. Further research for determining the optimal dose regimen for 
these patients is warranted.
